GATTEX (Teduglutide) Injection

GATTEX (teduglutide), from Takeda, is a GLP-2 analog indicated for adults and children 1 year and older with short bowel syndrome (SBS) who are dependent on parenteral (intravenous) nutrition support, to help improve intestinal absorption and reduce parenteral support needs.

Teduglutide promotes growth and repair of the intestinal lining and increases nutrient and fluid absorption, helping patients with SBS rely less on IV nutrition and hydration.

• Increased risk of colorectal polyps — colonoscopy is recommended before starting and periodically during treatment.
• Intestinal obstruction and biliary/pancreatic disorders have been reported.
• Fluid overload can occur as intestinal absorption improves — parenteral support may need dose adjustment.
• Common side effects: abdominal pain, nausea, injection-site reactions, headache, abdominal distension.

What documents are required to import GATTEX to India?

GATTEX may be imported in the patient’s name only, by patients or government hospitals. The following documentation is required:

• A valid prescription from a registered gastroenterologist
• Diagnostic report confirming short bowel syndrome and parenteral support dependence
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription and an import permit, if applicable.

Is GATTEX available in India?

GATTEX is not commercially marketed in India. It can be legally accessed through the Named Patient Program (NPP).

Indian Pharma Network (IPN) can source GATTEX from Takeda’s authorized distribution network and facilitate supply to patients, doctors, and hospitals. GATTEX requires cold-chain handling (refrigerated 2-8°C); IPN uses temperature-monitored logistics for every shipment.

For GATTEX cost in India and availability, contact IPN at Phone: +91-9310090915 or email info@indianpharmanetwork.in.

Global Approval Status:

• United States: Approved by the FDA — December 2012 (adults); extended to children 1 year and older in 2019.

What is GATTEX used for?

GATTEX helps reduce dependence on IV parenteral nutrition in patients with short bowel syndrome, by improving intestinal absorption.

Who manufactures GATTEX?

GATTEX is manufactured by Takeda Pharmaceutical Company Limited.

How is GATTEX administered?

As a once-daily subcutaneous injection, dosed at 0.05 mg/kg body weight.

How much does GATTEX cost in India?

Cost depends on body-weight dosing, sourcing logistics, and quantity — share your prescription with IPN for a quote.